Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Oct 1;137(4):883-891.
doi: 10.1152/japplphysiol.00340.2024. Epub 2024 Aug 8.

Silence of the lungs: comparing measures of slow and noncommunicating lung units from pulmonary function tests with computed tomography

Affiliations
Comparative Study

Silence of the lungs: comparing measures of slow and noncommunicating lung units from pulmonary function tests with computed tomography

Christopher Short et al. J Appl Physiol (1985). .

Abstract

Multiple breath washout (MBW) has successfully assessed the silent lung zone particularly in cystic fibrosis lung disease, however, it is limited to the communicating lung only. There are a number of different pulmonary function methods that can assess what is commonly referred to as trapped air, with varying approaches and sensitivity. Twenty-five people with cystic fibrosis (pwCF) underwent MBW, spirometry, body plethysmography, and spirometry-controlled computed tomography (spiro-CT) on the same day. PwCF also performed extensions to MBW that evaluate air trapping, including our novel extension (MBWShX), which reveals the extent of underventilated lung units (UVLU). In addition, we used two previously established 5-breath methods that provide a volume of trapped gas (VTG). We used trapped air % from spiro-CT as the gold standard for comparison. UVLU derived from MBWShX showed the best agreement with trapped air %, both in terms of correlation (RS 0.89, P < 0.0001) and sensitivity (79%). Bland-Altman analysis demonstrated a significant underestimation of the VTG by both 5-breath methods (-249 mL [95% CI -10,796; 580 mL] and -203 mL [95% CI -997; 591 mL], respectively). Parameters from both spirometry and body plethysmography were suboptimal at assessing this pathophysiology. The parameters from MBWShX demonstrated the best relationship with spiro-CT and had the best sensitivity compared with the other pulmonary function methods assessed in this study. MBWShX shows promise to assess and monitor this critical pathophysiological feature, which has been shown to be a driver of lung disease progression in pwCF.NEW & NOTEWORTHY We consider the term "trapped air" either in the use of imaging or pulmonary function testing, something of a misnomer that can lead to an inaccurate assessment of an important physiological feature. Instead, we propose the term underventilated lung units (UVLU). Of the many pulmonary function methods we used in this study, we found that the use of multiple breath washout with short extension (MBWShX) to be the best nonimaging method.

Keywords: air trapping; collateral ventilation; cystic fibrosis (CF); pulmonary function testing (PFT); pulmonary physiology.

PubMed Disclaimer

Conflict of interest statement

Harm Tiddens reports grants from Vectura Group Plc., other from Roche and Novartis, grants from CFF, Vertex, Gilead and Chiesi, outside the submitted work. In addition, Harm Tiddens has a patent Vectura licensed, and a patent PRAGMA-CF scoring system issued and is heading the Erasmus MC-Sophia Children’s Hospital Core Laboratory Lung Analysis. Paul McNally reports independent grants and speaker/board honoraria from Vertex outside the submitted work. Jane C Davies and her institution have received fees for Advisory Board participation, clinical trial leadership, and speaking engagements from Vertex Pharmaceuticals in the field of CFTR modulators but not directly related to this study, and from AbbVie, Arcturus, Boehringer Ingelheim, Eloox, Enterprise Thearpeutics and Novartis outside the scope of this work. None of the other authors has any conflicts of interest, financial or otherwise, to disclose.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Correlations between trapped air % from spirometry-controlled computed tomography and pulmonary function parameters including percent predicted (pp) forced expiratory volume in 1 second (FEV1), forced expiratory flow at 25–75% of the forced vital capacity (FVC) (FEF25–75%), flow when 75% of FVC has been exhaled (FEF75%) from spirometry and derivatives of Short extension multiple breath washout (MBWShX). Spearman’s correlation coefficient was used. Individual dots are color coded for a patient’s total lung capacity (TLC) which is measured in liters and is consistent on all scatter plots. UVLU, underventilated lung units.
Figure 2.
Figure 2.
Spearman’s correlation coefficient of the volume of trapped gas (VTG) over residual volume % from the 5 inspiratory capacity breaths (5IC) method (left) and 5 vital capacity (5VC) method (right) with trapped air % from spirometry-controlled computed tomography. There is a clear under-read of the of VTG/residual volume (RV)% from both 5-breath methods compared with the trapped air %. Straight black line is a linear regression line, with dashed lines either side the 95% confidence intervals.
Figure 3.
Figure 3.
We used the linear regression slope values from Fig. 2, to update the fundamental assumption of 78% N2 (16) concentration to find a better agreement between the 5-breath methods and trapped air %. For the 5 inspiratory capacity breaths (5IC) method, the 1/slope value was 3.823 whereas for the 5 vital capacity (5VC) method, the 1/slope value was 2.979. Therefore, we recalculated the volume of trapped gas (VTG)/residual volume (RV)% for the 5IC method using a N2 of 20.40% (78/3.823) and 5VC breaths using a N2 of 26.183% (78/2.979) (Fig. 4). As would be expected, the correlation coefficient for both parameters stayed the same, but now the agreement on the extent of trapped air % was almost perfect with a 1/slope 1.00 for both parameters.
Figure 4.
Figure 4.
As seen in Fig. 3, a fixed correction factor applied to the assumption of N2 concentration of “trapped air” spaces still did not improve the correlation coefficient or remove large outliers, when comparing volume of trapped gas with trapped air%. Therefore, we used a molarity calculator to model the N2% for an individual patient that was likely present in the “trapped air” spaces which would generate a perfect agreement with trapped air % from spirometry-controlled computed tomography. Each dot is color coded for the N2% modeled to generate that perfect agreement. Note the patients in red had a larger volume of trapped gas (VTG) over residual volume % (RV%) than trapped air %, therefore N2 concentration could not be calculated. The range for N2% for the 5 inspiratory capacity breaths (5IC) method was 3.5% to 34.8% and for the 5 vital capacity (5VC) was 8.6% to 55.3%. Without having the accompanying trapped air% values calculating an accurate VTG/RV% is not possible.
Figure 5.
Figure 5.
Axial computed tomography (CT) with inspiratory image left (A) and expiratory image right (B), subsegmental posterior-basal left lower lobe. The airway pointed out with the red arrow is patent, but ectatic on the inspiratory image, but collapses on the forced expiratory image. The adjacent low attenuation (inside red dashed line) is generally interpreted as “small airways disease” or “trapped air,” but the nonphysiologic larger airways collapse could contribute to this appearance. This participant had a percent predicted forced expiratory volume in 1 second (ppFEV1) of 83% and Z-score of −1.36. The location of the collapsed airway is at the 6th generation, which is still within the proximal airways.

References

    1. Macklem PT. The physiology of small airways. Am J Respir Crit Care Med 157: S181–S183, 1998. doi:10.1164/ajrccm.157.5.rsaa-2. - DOI - PubMed
    1. Macklem PT. Airway obstruction and collateral ventilation. Physiol Rev 51: 368–436, 1971. doi:10.1152/physrev.1971.51.2.368. - DOI - PubMed
    1. Rosenthal M. Annual assessment spirometry, plethysmography, and gas transfer in cystic fibrosis: do they predict death or transplantation: lung function and prognosis in cystic fibrosis. Pediatr Pulmonol 43: 945–952, 2008. doi:10.1002/ppul.20879. - DOI - PubMed
    1. Davies JC, Sermet-Gaudelus I, Naehrlich L, Harris RS, Campbell D, Ahluwalia N, Short C, Haseltine E, Panorchan P, Saunders C, Owen CA, Wainwright CE;. VX16-661-115 Investigator Group. A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation. J Cyst Fibros 20: 68–77, 2021. doi:10.1016/j.jcf.2020.07.023. - DOI - PubMed
    1. Kent L, Reix P, Innes JA, Zielen S, Le Bourgeois M, Braggion C, Lever S, Arets HGM, Brownlee K, Bradley JM, Bayfield K, O'Neill K, Savi D, Bilton D, Lindblad A, Davies JC, Sermet I, De Boeck K;. European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee. Lung clearance index: evidence for use in clinical trials in cystic fibrosis. J Cyst Fibros 13: 123–138, 2013. doi:10.1016/j.jcf.2013.09.005. - DOI - PubMed

Publication types